ecancer

Highlights from ASCO 2021

Dr Bishal Gyawali - Queen's University, Kingston, Canada

8 Jun 2021

OncoAlert and ecancer weekly roundup for April 19 - 25, 2021

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden

26 Apr 2021

Safety and efficacy of atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma

Prof Richard Finn - Geffen School of Medicine at UCLA, Los Angeles, USA

13 Apr 2021

Efficacy and safety of selpercatinib in RET fusion-positive cancers other than lung or thyroid cancers

Prof Vivek Subbiah - MD Anderson Cancer Center, Houston, USA

13 Apr 2021

High-quality neoantigens are immunoedited in long-term survivors of pancreatic cancer

Prof Marta Luksza - Tisch Cancer Institute, New York, USA

12 Apr 2021

OncoAlert and ecancer weekly roundup for February 01 - 06, 2021

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden

9 Feb 2021

OncoAlert Colloquium Day 1: GI tumours and MASCC

Dr Eng, Dr Cervantes, Dr Janjigian, Dr Lewis, Dr George, Dr Lustberg, Dr Chan, Dr Scotte

23 Dec 2020

Targeting a KRAS neoantigen peptide vaccine to DNGR-1 dendritic cells

Dr Rachel Ambler - The Francis Crick Institute, London, United Kingdom

27 Nov 2020

OncoAlert and ecancer weekly roundup for November 15 - 21, 2020

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden

27 Nov 2020

OncoAlert and ecancer weekly roundup for November 2 - 7, 2020

Dr Gil Morgan - Skåne University Hospital, Lund, Sweden

9 Nov 2020

Bevacizumab-induced hypertension and proteinuria: A genome-wide analysis of more than 1,000 patients

Prof Federico Innocenti - University of North Carolina, Chapel Hill, USA

4 Nov 2020

Updates in geriatric medical oncology from SIOG meeting

Dr Enrique Soto - Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico

28 Oct 2020

More from ecancer